UBS Upgrades Bruker BioSciences After Firm Announces Plan to Buy Bruker Optics | GenomeWeb

UBS Upgrades Bruker BioSciences After Firm Announces Plan to Buy Bruker Optics

Apr 20, 2006

NEW YORK, April 20 (GenomeWeb News) - UBS today upgraded its assessment of Bruker BioSciences to "Buy" from "Neutral," two days after Bruker announced plans to purchase privately held Bruker Optics.

As GenomeWeb News reported on Tuesday, Bruker said it plans to pay $135 million for Bruker Optics, which makes molecular spectroscopy platforms, the companies said this week.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Threats of Synthetic Biology

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

Deletion Is Hard to Do

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

So Just How Many Are There?

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

This Week in Genome Research

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.